Cargando…

Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?

Trypanosoma brucei gambiense causes human African trypanosomiasis (HAT). Between 1990 and 2015, almost 440 000 cases were reported. Large-scale screening of populations at risk, drug donations, and efforts by national and international stakeholders have brought the epidemic under control with <22...

Descripción completa

Detalles Bibliográficos
Autores principales:	Büscher, Philippe, Bart, Jean-Mathieu, Boelaert, Marleen, Bucheton, Bruno, Cecchi, Giuliano, Chitnis, Nakul, Courtin, David, Figueiredo, Luisa M., Franco, José-Ramon, Grébaut, Pascal, Hasker, Epco, Ilboudo, Hamidou, Jamonneau, Vincent, Koffi, Mathurin, Lejon, Veerle, MacLeod, Annette, Masumu, Justin, Matovu, Enock, Mattioli, Raffaele, Noyes, Harry, Picado, Albert, Rock, Kat S., Rotureau, Brice, Simo, Gustave, Thévenon, Sophie, Trindade, Sandra, Truc, Philippe, Van Reet, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840517/ https://www.ncbi.nlm.nih.gov/pubmed/29396200 http://dx.doi.org/10.1016/j.pt.2017.11.008

Ejemplares similares

Untreated Human Infections by Trypanosoma brucei gambiense Are Not 100% Fatal
por: Jamonneau, Vincent, et al.
Publicado: (2012)

Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis
por: Dama, Emilie, et al.
Publicado: (2019)

The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense
por: Leong, Smiths, et al.
Publicado: (2013)

Correction: The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense
por: Lueong, Smiths, et al.
Publicado: (2013)

Accuracy of Individual Rapid Tests for Serodiagnosis of Gambiense Sleeping Sickness in West Africa
por: Jamonneau, Vincent, et al.
Publicado: (2015)

Experimental evidence that immune trypanolysis using the LiTat 1.3 and LiTat 1.5 variant antigen types is not specific to Trypanosoma brucei gambiense in pigs
por: Ilboudo, Kadidiata, et al.
Publicado: (2022)

Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d’Ivoire
por: Ahouty, Bernardin, et al.
Publicado: (2017)

Target product profile: diagnostic test for Trypanosoma brucei gambiense
por: Priotto, Gerardo, et al.
Publicado: (2023)

Target product profile: Trypanosoma brucei gambiense test to verify elimination
por: Priotto, Gerardo, et al.
Publicado: (2023)

Target product profile: Trypanosoma brucei gambiense test for low-prevalence settings
por: Priotto, Gerardo, et al.
Publicado: (2023)

The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Côte d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense
por: N’Djetchi, Martial Kassi, et al.
Publicado: (2017)

Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea
por: Kaboré, Justin Windingoudi, et al.
Publicado: (2017)

Extravascular Dermal Trypanosomes in Suspected and Confirmed Cases of gambiense Human African Trypanosomiasis
por: Camara, Mariame, et al.
Publicado: (2020)

Gambiense human African trypanosomiasis: the bumpy road to elimination
por: Hasker, Epco, et al.
Publicado: (2022)

Revisiting the Immune Trypanolysis Test to Optimise Epidemiological Surveillance and Control of Sleeping Sickness in West Africa
por: Jamonneau, Vincent, et al.
Publicado: (2010)

Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections
por: Bucheton, B, et al.
Publicado: (2011)

Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso
por: Compaoré, Charlie Franck Alfred, et al.
Publicado: (2022)

A targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’Ivoire
por: Koffi, Mathurin, et al.
Publicado: (2016)

Serological tests for gambiense human African trypanosomiasis detect antibodies in cattle
por: Matovu, Enock, et al.
Publicado: (2017)

Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness
por: Castaño, M Soledad, et al.
Publicado: (2020)

Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis
por: Ilboudo, Hamidou, et al.
Publicado: (2017)

Vers l’élimination de la maladie du sommeil
por: Solano, Philippe, et al.
Publicado: (2023)

APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
por: Cooper, Anneli, et al.
Publicado: (2017)

Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda – Moving towards elimination
por: Wamboga, Charles, et al.
Publicado: (2017)

Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with “screen, diagnose and treat” using innovative tools and strategies
por: Ndung’u, Joseph Mathu, et al.
Publicado: (2020)

Implications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and Control
por: Stone, Chris M., et al.
Publicado: (2015)

Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection
por: Ngay Lukusa, Ipos, et al.
Publicado: (2021)

Luminescent multiplex viability assay for Trypanosoma brucei gambiense
por: Van Reet, Nick, et al.
Publicado: (2013)

Cerebrospinal Fluid Neopterin as Marker of the Meningo-Encephalitic Stage of Trypanosoma brucei gambiense Sleeping Sickness
por: Tiberti, Natalia, et al.
Publicado: (2012)

Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d’Ivoire using an integrated approach
por: Kaba, Dramane, et al.
Publicado: (2023)

Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling
por: Rock, Kat S, et al.
Publicado: (2018)

Neopterin Is a Cerebrospinal Fluid Marker for Treatment Outcome Evaluation in Patients Affected by Trypanosoma brucei gambiense Sleeping Sickness
por: Tiberti, Natalia, et al.
Publicado: (2013)

Performance of diagnostic tests for Trypanosoma brucei brucei in experimentally infected pigs
por: Ilboudo, Kadidiata, et al.
Publicado: (2023)

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study
por: Ngay Lukusa, Ipos, et al.
Publicado: (2022)

A polymorphism in the haptoglobin, haptoglobin related protein locus is associated with risk of human sleeping sickness within Cameroonian populations
por: Ofon, Elvis, et al.
Publicado: (2017)

Two-Year Follow-Up of Trypanosoma brucei gambiense Serology after Successful Treatment of Human African Trypanosomiasis: Results of Four Different Sero-Diagnostic Tests
por: Inocencio da Luz, Raquel, et al.
Publicado: (2022)

Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis
por: Geerts, Manon, et al.
Publicado: (2020)

High Levels of Genetic Diversity within Nilo-Saharan Populations: Implications for Human Adaptation
por: Mulindwa, Julius, et al.
Publicado: (2020)

Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo
por: Aliee, Maryam, et al.
Publicado: (2021)

Modelling to Quantify the Likelihood that Local Elimination of Transmission has Occurred Using Routine Gambiense Human African Trypanosomiasis Surveillance Data
por: Davis, Christopher N, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k5qlgnin4n2duuaccvajfkae28